COPD: Causes, Symptoms, Treatment

COPD: Causes, Symptoms, Treatment

Chronic Obstructive Pulmonary Disease (COPD) remains one of the most significant respiratory challenges globally. As of 2026, it is the third leading cause of death worldwide. This guide provides the most current clinical facts on managing this progressive lung condition.

1. What is COPD? (Definition & Types)

COPD is a chronic inflammatory lung disease that causes obstructed airflow from the lungs. It is an “umbrella term” that typically involves two main conditions:

• Emphysema: Damage to the air sacs (alveoli), reducing oxygen exchange.

• Chronic Bronchitis: Permanent inflammation of the bronchial tubes, causing excess mucus and a persistent cough.

2. Epidemiology and Prevalence in 2026

In the UK alone, over 1.2 million people live with diagnosed COPD. However, it is estimated that millions more remain undiagnosed. While historically associated with older male smokers, we are seeing rising rates in women and younger populations due to combined environmental factors.

3. Key Risk Factors: Beyond Just Smoking

While tobacco use accounts for roughly 80% of cases, other critical risk factors include:

• Environmental Exposure: Long-term exposure to air pollution and biomass fuels.

• Occupational Hazards: Chronic inhalation of chemical fumes, dusts, and vapors.

• Genetics: Alpha-1 Antitrypsin Deficiency (AATD) is a hidden genetic cause that should be screened for in younger patients.

• Socioeconomic Factors: Strong correlations exist between deprivation and COPD prevalence.

4. Recognising the 5 Common Signs

COPD symptoms often don’t appear until significant lung damage has occurred. Watch for:

1. Progressive Breathlessness: Difficulty breathing during daily activities (e.g., walking up stairs).

2. The “Smoker’s Cough”: A persistent, productive cough with clear, white, yellow, or greenish phlegm.

3. Wheezing and Chest Tightness: Often mistaken for asthma.

4. Frequent Respiratory Infections: Getting “chest colds” more often than others.

5. Cyanosis: A bluish tint to the lips or fingernail beds (indicating low oxygen).

5. Modern Diagnosis and Differential Thinking

The “Gold Standard” for diagnosis remains Spirometry. A post-bronchodilator $FEV_1/FVC$ ratio of less than 0.7 confirms persistent airflow limitation.

Expert Note on Differential Diagnosis:

If a patient is a non-smoker or from a Black or Asian background, clinicians should also investigate Bronchiectasis, Pulmonary Fibrosis, or Sarcoidosis, which can mimic COPD symptoms but require different management pathways.

6. 2026 Treatment Standards

Management has shifted toward multidisciplinary, personalised care.

• Triple Therapy Inhalers: Combined LAMA/LABA/ICS inhalers are now the standard for patients with frequent exacerbations.

• Pulmonary Rehabilitation: A structured exercise and education program proven to be as effective as medication for improving quality of life.

• Biologics: In 2026, targeted biologic therapies are increasingly used for “eosinophilic” COPD phenotypes.

• Surgical Interventions: Including lung volume reduction surgery (LVRS) or endobronchial valves for severe emphysema.

7. When to See a Specialist

Urgent cardiology or respiratory referral is required if:

• Symptoms worsen despite inhaler use.

• You experience sudden exacerbations (a “flare-up” of symptoms).

• There are signs of Cor Pulmonale (right-sided heart failure caused by lung disease), such as swollen ankles.

8. Prevention and Lifestyle

The most effective way to prevent COPD—or stop its progression—is Smoking Cessation. Additionally, staying up to date with Influenza, COVID-19, and Pneumococcal vaccinations is vital to prevent life-threatening lung infections.

Summary Table: COPD at a Glance

Are you experiencing persistent breathlessness? Contact your GP for a spirometry test. Early intervention is the key to maintaining your lung function and independence.